Q

Qingdao Baheal Medical Inc
SZSE:301015

Watchlist Manager
Qingdao Baheal Medical Inc
SZSE:301015
Watchlist
Price: 29.05 CNY -5.03% Market Closed
Market Cap: 15.3B CNY
Have any thoughts about
Qingdao Baheal Medical Inc?
Write Note

Qingdao Baheal Medical Inc
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Qingdao Baheal Medical Inc
Net Income (Common) Peer Comparison

Comparables:
1099
601607
600998
C
600511
000963

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Q
Qingdao Baheal Medical Inc
SZSE:301015
Net Income (Common)
ÂĄ656.3m
CAGR 3-Years
34%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Sinopharm Group Co Ltd
HKEX:1099
Net Income (Common)
ÂĄ8.7B
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
13%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Net Income (Common)
ÂĄ4.1B
CAGR 3-Years
-10%
CAGR 5-Years
0%
CAGR 10-Years
6%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Net Income (Common)
ÂĄ2B
CAGR 3-Years
-19%
CAGR 5-Years
9%
CAGR 10-Years
15%
C
China National Medicines Corp Ltd
SSE:600511
Net Income (Common)
ÂĄ2.2B
CAGR 3-Years
12%
CAGR 5-Years
7%
CAGR 10-Years
17%
Huadong Medicine Co Ltd
SZSE:000963
Net Income (Common)
ÂĄ3.1B
CAGR 3-Years
9%
CAGR 5-Years
4%
CAGR 10-Years
17%

See Also

What is Qingdao Baheal Medical Inc's Net Income (Common)?
Net Income (Common)
656.3m CNY

Based on the financial report for Dec 31, 2023, Qingdao Baheal Medical Inc's Net Income (Common) amounts to 656.3m CNY.

What is Qingdao Baheal Medical Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
21%

Over the last year, the Net Income (Common) growth was 31%. The average annual Net Income (Common) growth rates for Qingdao Baheal Medical Inc have been 34% over the past three years , 21% over the past five years .

Back to Top